Metraipolis › archive › dc_74b385209447
Targeting ACE2 with a camelid antibody inhibits SARS-CoV-2 binding and has protective effects in vivo — Europe PMC PMID:41271706
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41271706
- DOI
- 10.1038/s41467-[numero omesso]-w
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T09:00:44.020Z
- SHA-256 of the archived text
2af9d518e021c240ffa419430e77129e1a3f59c11501f77e04e592d5aaebfe7a- Stable URL of this page
https://metraipolis.com/documento/dc_74b385209447
How to cite
Targeting ACE2 with a camelid antibody inhibits SARS-CoV-2 binding and has protective effects in vivo — Europe PMC PMID:41271706 — Europe PMC (en), https://europepmc.org/article/MED/41271706 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_74b385209447 (Metraipolis archive dc_74b385209447, sha256 2af9d518e021c240ffa419430e77129e1a3f59c11501f77e04e592d5aaebfe7a)
BibTeX
@misc{dc74b385209447,
title = {Targeting ACE2 with a camelid antibody inhibits SARS-CoV-2 binding and has protective effects in vivo — Europe PMC PMID:41271706},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41271706},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_74b385209447; sha256 2af9d518e021c240ffa419430e77129e1a3f59c11501f77e04e592d5aaebfe7a},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41271706. Agents can read the archived copy with the MCP tool read_document.